Studies from University of Sydney Have Provided New Data on Musculoskeletal Disorders (Positive recovery for low-risk injuries screened by the short form – Orebro musculoskeletal pain screening questionnaire following road traffic injury: …)

2019 DEC 12 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Daily -- Current study results on Diseases and Conditions - Musculoskeletal Disorders have been published. According to news reporting originating in Sydney, Australia, by NewsRx journalists, research stated, “Prognosis of musculoskeletal disorders following injury is essential in determining appropriate treatment and care. A generic validated prognostic tool to stratify risk of poor recovery for people with musculoskeletal injuries after road traffic crash is not available.”

Financial support for this research came from State Insurance Regulatory Authority of New South Wales, Australia.

The news reporters obtained a quote from the research from the University of Sydney, “This study aimed to examine differences in recovery, return to work and health related quality of life between low and high-risk of poor recovery people with musculoskeletal injuries stratified by the Short form - orebro Musculoskeletal Pain Screening Questionnaire (SF-OMPSQ). In an inception cohort study, participants with non-fracture musculoskeletal injury with the main site being the neck, lower back or lower limb were stratified into low (score <= 50) and high (score > 50) risk of poor recovery using the SF-OMPSQ score at baseline. We assessed the proportion of fully recovered participants (Global Perceived Effect scale >= 4), the proportion returning to work and changes in short form 12-item (SF-12) scores between baseline and 6-month follow-up in low and high-risk groups. Modified Poisson regression was used to estimate the adjusted risk ratio (RR) of being recovered and return to work in the low and high-risk groups. Paired t-test was used to compare changes in SF-12 physical and mental component summary scales, and chi-square test was used to assess the significance of the risk ratio of fully recovered between low and high-risk groups. The study included 498 participants (166 with neck, 78 with lower back and 254 with lower limb injuries). The proportion of being recovered was significantly higher in the low than the high-risk groups (Adjusted risk ratio: 2.96 [95% CI: 1.81 to 4.82]). Significantly more people in the low-risk group returned to work (91.0%) than the high-risk group (54.6%). People at low-risk had higher SF-12 scores at baseline and 6-month follow-up than those at high-risk. There were no differences between injury types for recovery and return to work at 6 months.”

According to the news reporters, the research concluded: “The SF-OMPSQ could be recommended as a generic prognostic tool to identify individuals with musculoskeletal injuries early after road traffic injury, who would have a higher or lower likelihood of recovering or returning fully to pre-injury work.”

For more information on this research see: Positive recovery for low-risk injuries screened by the short form - Orebro musculoskeletal pain screening questionnaire following road traffic injury: evidence from an inception cohort study in New South Wales, Australia. BMC Musculoskeletal Disorders, 2019;20(1):. BMC Musculoskeletal Disorders can be contacted at: Bmc, Campus, 4 Crinan St, London N1 9XW, England. (BioMed Central - http://www.biomedcentral.com/; BMC Musculoskeletal Disorders - http://www.biomedcentral.com/bmcmusculoskeletdisord/)

Our news correspondents report that additional information may be obtained by contacting H. Nguyen, University of Sydney, John Walsh Ctr Rehabil Res, Sydney, Nsw, Australia. Additional authors for this research include T. Rebbeck, A. Kifley, J. Jagnoor, I.D. Cameron, M. Dinh, A. Shetty and M. Nicholas.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1186/s12891-019-2881-9. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)